Zivo Bioscience Inc (ZIVO)

[Amigo Mike]

Not sure why you guys waste your time on comments that offer no value to anyone.

Anyway ..... looks to me like another 100k block dropped on the stock this morning with no limit again. Cut right through each bid until done. The stock faces an additional uphill battle now. ~6-7 weeks til EOY and only a nimble trader could claim any profit in the stock this year. Tax loss selling against the broader market gains is likely to be a factor even if a deal is struck before year end.

Isn't it interesting that every time Dahl opens his mouth the stock invariably falls. Red Chip clearly altering the message and trying to help Dahl articulate the message better although I still think he fumbled the ball again. In listening again to the interview, Dahl says there would be a longer term study after the bovine pilot, but he does not articulate WHEN licensing by Zoetis might occur. After the pilot and before longer term study or after longer term study because he later says license short term. ZIVO certainly cannot fund a longer term study which certainly would be required for the direct injection product. Makes sense for license and development deal after pilot but again ...... Its all about clarity.

Time for Dahl to show whether he is a producer or not. Wellmetris he is clearly saying they've refined the product and have reduced costs and are ready to go contacting potential partners and potential customers. IMO has to focus on partner. Customers can come later. A medical device company or insurer by default would have hooks into potential customers already on their book of business. So focus has to be on right partner and getting this launched.

I think I'll set up some trade triggers under the market here to see if I can pick off some shares if someone is going to continue to sell like that.

Market cap at roughly $12 million. Development deal for mastitis and ..... mycoplasma which opens door to entire bovine market ...... Could easily exceed entire market cap. The question is whether the bioactive produces significant enough results and Dahl can deliver a license. If I were he, every major animal pharma would be hearing about our results and first to the table gets in the do.

Amigo Mike